Sartorius Stedim Biotech S.A.
SDMHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $1 |
| Gross Profit | $1 | $1 | $2 | $2 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $1 | $1 |
| % Margin | 13.3% | 16.2% | 28.5% | 30% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | $0 | $0 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS | 1.81 | 3.36 | 9.51 | 4.5 |
| % Growth | -46.1% | -64.7% | 111.3% | – |
| EPS Diluted | 1.81 | 3.36 | 9.51 | 4.5 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 24.1% | 27.2% | 38.1% | 27.7% |